期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
政府投资项目代建人前期代理管理成果评价及案例研究 被引量:3
1
作者 乌云娜 黄勇 +1 位作者 李泽众 赵娜 《华东经济管理》 CSSCI 2012年第5期146-152,共7页
文章基于代建制前期代理和中期代建的两阶段划分理念,分析了代建人管理成果指标体系的特征、原则和操作方法。以前期代理为切入点,定义了前期代理管理的范畴,分析了项目前期工作内容,重点研究了代建人前期代理管理成果评价模型。模型以... 文章基于代建制前期代理和中期代建的两阶段划分理念,分析了代建人管理成果指标体系的特征、原则和操作方法。以前期代理为切入点,定义了前期代理管理的范畴,分析了项目前期工作内容,重点研究了代建人前期代理管理成果评价模型。模型以定性指标与定量指标相结合的原则,以便于动态反映管理过程和结果。将专家调查法分别与熵理论和层次分析法结合,对初拟的指标进行筛选、确定权重,建立模糊综合评价模型,构建了前期代理评价体系。最后选取了二个有代表性的案例进行实证研究,说明本评价体系如何在动态评价和静态评价中的应用,验证了所建指标和评价体系的实用性。 展开更多
关键词 政府投资项目 代建人 前期代理 管理成果 综合评价
下载PDF
A probiotic treatment containing Lactobacillus,Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial 被引量:33
2
作者 FAN yu-jing CHEN Shu-jie +2 位作者 YU Ying-cong SI Jian-min LIU Bin 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2006年第12期987-991,共5页
Objective: To evaluate the efficacy and safety of live combined Bifidobacterium, Lactobacillus and Enterococcus capsules in treatment of irritable bowel syndrome, Methods: Eighty-fve patients [male 32, female 53; a... Objective: To evaluate the efficacy and safety of live combined Bifidobacterium, Lactobacillus and Enterococcus capsules in treatment of irritable bowel syndrome, Methods: Eighty-fve patients [male 32, female 53; age (45.31±11,72) years] were given live combined Bifidobacterium, Lactobacillus and Enterococcus capsules 1260 mg/d t.i.d. ×4 weeks. Syndrome scales were used to evaluate the efficacy in gastrointestinal syndrome. Fecal flora was also measured before and after the treatment. Six bacteria were cultured and the colony forming units were counted in stool. SPSS was used for data analysis. Results: Seventy-four patients finished the follow-up. No side-effect was found. For treatment of irritable bowel syndrome, the effective rate of live combined Bifidobacterium, Lactobacillus and Enterococcus capsules was 56.8% in the second week, 74.3% in the fourth week and 73.0% in the sixth week. Single symptom was improved, especially in abdominal pain and stool character. The probiotica containing live combined Bifidobacterium, Lactobacillus and Enterococcus could increase bifidobacterium count (P〈0.01) and lactobacillus count (P〈0.05); decrease bacteroides count (P〈0.05) and enterococci count (P〈0.01); No obvious changes were observed in clostridium diffcile colonitis and enterobacteriaceae (P〉0.05). Conclusion: The result of the study indicated that the administration of live combined Bifidobacterium, Lactobacillus and Enterococcus improved the symptom of irritable bowel syndrome and that there was a gradual increase of this effect. Thereafter conditions remained stable for 2 weeks. That improvement may be associated with alterations in gastrointestinal flora. 展开更多
关键词 Irritable bowel syndrome (IBS) Intestinal flora Probiotic agents
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部